1. Vaccarino V. The association between depression and coronary heart disease incidence. Drugs Today (Barc). 2000; 36 (10):715–24.
2. Brunner J, Parhofer K.G, Schwandt P, Bronisch T. Cholesterol, essential fatty acids, and suicide. Pharmacopsychiatry. 2002;35:1–5.
3. Manfredini R, Caracciolo S, Salmi R, Boari B, Tomelli A, Galleranie M. association of low serum cholesterol with depression and suicidal behaviors: new hypotheses for the missing link. Journal of International Medical Research. 2000;28: 247–257.
4. Borgherini G, Dorz S, Conforti D, Scarso C, Magni G. Serum cholesterol and psychological distress in hospitalized depressed patients. Acta Psychiatrica Scandinavica. 2002;105:149–152.
5. Ellison LF, Morrison HI. Low serum cholesterol concentration and risk of suicide. Epidemiology. 2001;12:168–172.
6. Horsten M, Wamala S, Vingerhoets A, Orth-Gomer K. . Depressive symptoms, social support, and lipid profile in healthy middle-aged women. Psychosom Med. 1997;59:521–8.
7. Blazer DG, Burchett BB, Fillenbaum GC. APOE epsilon4 and low cholesterol as risks for depression in a biracial elderly community sample. American Journal of Geriatric Psychiatry. 2002;10: 515–520.
8. Chen CC, Lu FH, Wu JS, Chang CJ.. Correlation between serum lipid concentrations and psychological distress. Psychiatry Research. 2001;102:153–162.
9. Hayward C. Anxiety disorders and serum lipids. In: Hillbrand M, Spitz RT, editors. Lipids, health, and behavior. Washington DC: American Psychological Association. 1997;69–79.
10. Kagan BL, Leskin G, Haas B, Wilkins J., Foy D. Elevated lipid levels in Vietnam veterans with chronic posttraumatic stress disorder. Biol Psychiatry. 1999;45:374–7.
12. Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE.. Depression and poor glycemic control: a meta- analytic review of the literature. Diabetes Care. 2000; 23:934–942.
13. Pouwer F, Geelhoed-Duijvestijn PH, Bazelmans E, Beekman AJ, Heine RJ et al. Prevalence of comorbid depression is high in out-patients with type 1 or type 2 diabetes mellitus. Results from three out-patient clinics in the Netherlands. Diabet Med. 2010;27:217–224.
14. Park M, Katon WJ, Wolf FM. Depression and risk of mortality in individuals with diabetes: a meta-analysis and systematic review. Gen Hosp Psychiatry. 2013;35:217–225.
15. Lin EH, Heckbert SR, Rutter CM, Katon WJ, Ciechanowski P, Ludman EJ et al. Depression and increased mortality in diabetes: unexpected causes of death. Ann Fam Med. 2009;7:414–421.
16. vanDooren FE, Nefs G, Schram MT, Verhey FR, Denollet J, Pouwer F. Depression and risk of mortality in people with diabetes mellitus: a systematic review and meta-analysis. PLoSOne. 2013; 8:e57058.
17. Hamer M, Stamatakis E, Kivimaki M, Pascal Kengne A, Batty GD. Psychological distress, glycated hemoglobin, and mortality in adults with and without diabetes. Psychosom Med. 2010; 72:882–886.
18. Ali S, Stone MA, Peters JL, Davies MJ, Khunti K.. The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med. 2006;23:1165–1173.
19. Smith KJ, Beland M, Clyde M, Gariépy G, Pagé V, Badawi G, et al. Association of diabetes with anxiety: a systematic review and meta-analysis. J Psychosom Res. 2013;74:89–99.
20. Shrivastava S, Pucadyil TJ, Paila YD, Ganguly S, Chattopadhyay A.. Chronic cholesterol depletion using statin impairs the function and dynamics of human serotonin 1A receptors. Biochemistry. 2010;49:5426–5435.
21. Gabriel A. Changes in plasma cholesterol in mood disorder patients: does treatment make a difference? J Affect Disord. 2007;99:273–278.
22. Warnick GR, Benderson J, Albers JJ. Dextran sulfate Mg2+ precipitation procedure for quantitation of high- density lipoprotein cholesterol. Clinical Chemistry. 1982;28(6): 1379–88
23. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry. 1972;18: 499–502.
24. Zigmond AS, Sanith RP. The hospital anxiety and depression scale. Acta Psychaitr Scand. 1983;67:361–370.
25. El Raufaie OE, Absood G. Validity study of the hospital anxiety and depression scale among a group of Saudi patients. Br J Psychiatry. 1987;151:687–688.
26. El Rufaie OE, Absood GH, Abou-Saleh MT. Retesting the validity of the Arabic version of the hospital anxiety and depression (HAD) scale in primary health care. Soc Psychiatry Psy- chiatr Epidemiol. 1995;30:26–31.
27. Hermann C. International experiences with the Hospital Anxiety and depression Scale. A review of validation data and clinical results. J Psychosom Res. 1997;42:17–41.
28. Michopoulos I, Douzenis A, Kalkavoura C, Fineti K, Kalemi G, Psarra M, et al. Hospital Anxiety and Depression Scale (HADS): validation in a Greek general hospital sample. Psychiatriki. 2007;18(3): 217–24.
29. Bjelland I, Dahl AA, Haug TT, Neckelmann D.. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res. 2002;52(2):69–77.
30. Lehto SM, Hintikka J, Niskanen L, Tolmunen T, KoivumaaHonkanen H, Honkalampi K et al. Low HDL cholesterol associates with major depression in a sample with a 7-year history of depressive symptoms. Prog Neuropsychopharmacol Biol Psychiatr. 2008;32:1557–61.
32. Hibbeln JR, Linnoila M, Umhau JC, Rawlings R, George DT, Salem N Jr.. Essential fatty acids predict metabolites of serotonin and dopa- mine in cerebrospinal fluid among healthy control subjects, and early- and late-onset alcoholics. Biol Psychiatry. 1998;44:235–42.
33. Bonnet F, Irving K, Terra JL, Nony P, Berthezene F, Moulin P. Depressive symptoms are associated with unhealthy lifestyles in hypertensive patients with the metabolic syndrome. J Hypertens 2005;23(3):611–7.
34. Charney DS, Redmond EE. Neurobiological mechanisms in human anxiety: evidence supporting central noradrenergic hyperactivity. Neuropharmacology. 1983;22:1531–6.
35. Villacres EC, Hollifield M, Katon WJ. Sympathetic nervous system activity in panic disorder. Psychiatry Res. 1987;21:313–21.